Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Deciphera Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Deciphera Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Deciphera Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is DCPH. The reporting company's CIK number is 1654151.
The total value of stock buying since 2005 is $12,750,000.
The total value of stock sales since 2005 is $133,700.
The total value of stock option exercises since 2005 is $10,017.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-01-11||Flynn Daniel Lee (Chief Scientific Officer)||Sale||300||26.00||7,800|
|2019-01-11||Flynn Daniel Lee (Chief Scientific Officer)||Option Ex||300||1.89||567|
|2019-01-07||Kelly Thomas Patrick (Chief Financial Officer)||Sale||5,000||25.18||125,900|
|2019-01-07||Kelly Thomas Patrick (Chief Financial Officer)||Option Ex||5,000||1.89||9,450|
|2017-10-02||New Leaf Bpo Associates I, L.p. (10% Owner)||Buy||375,000||17.00||6,375,000|
|2017-10-02||Ratcliffe Liam (Director)||Buy||375,000||17.00||6,375,000|
Insider trading activities including stock purchases, stock sales, and option exercises of DCPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Deciphera Pharmaceuticals, Inc. (symbol DCPH, CIK number 1654151) see the Securities and Exchange Commission (SEC) website.